A Randomized Trial of Ambisome Monotherapy and Combination of Ambisome and Miltefosine for the Treatment of VL in HIV Positive Patients in Ethiopia Followed by Secondary VL Prophylactic Treatment With Pentamidine
Phase of Trial: Phase III
Latest Information Update: 09 Apr 2019
Price : $35 *
At a glance
- Drugs Amphotericin B liposomal (Primary) ; Miltefosine
- Indications Visceral leishmaniasis
- Focus Therapeutic Use
- 04 Apr 2019 Status changed from active, no longer recruiting to completed.
- 31 Aug 2018 Biomarkers information updated
- 18 Mar 2016 Planned primary completion date changed from 1 Jan 2016 to 1 Aug 2016 as reported by ClinicalTrials.gov.